A black eye on hormone therapy (HT) lingers two decades after researchers halted the HT arm of the largest-ever U.S. women’s prevention study in 2002. The news of an increased risk of breast cancer ignited a massive media response, scaring millions of women and their doctors away from HT and nearly delivering the menopause treatment a knockout punch.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
At a roundtable discussion on global health, University of Colorado Anschutz Medical Campus faculty briefed U.S. Rep. Jason Crow (D-Colo.) on the many ways CU Anschutz is transforming trauma care in austere settings and training […]
Researchers at the Colorado School of Public Health (CSPH) are studying how cannabis use affects driving performance. Using a “video game-like” simulator, they measure how people drive before and after consuming cannabis. Click here to […]
ATLANTA, March 11, 2025 /PRNewswire/ — Swisslog, a leading provider of best-in class warehouse automation and software, today announced that long-time customer Medline will deploy an AutoStore system optimized by Swisslog’s SynQ software within its […]
Copyright © 2026 Biotech Networks
